$Recro Pharma, Inc.(REPH)$ 8-K - Current report Filed: 2017-11-14 AccNo: 0001193125-17-342627 Size: 20 MBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接